STANDARD BIOTOOLS INC. (LAB) Retained Earnings (Accumulated Deficit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Standard Biotools Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2010 to 2024.
  • Standard Biotools Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$1.08 B, a 14.4% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$1.08 B -$136 M -14.4% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$1 B -$74.7 M -8.06% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 -$981 M -$75.7 M -8.37% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$960 M -$84.2 M -9.61% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$943 M -$131 M -16.1% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 -$926 M -$190 M -25.8% Dec 31, 2022 10-K 2024-03-01
Q3 2022 -$905 M -$179 M -24.6% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 -$876 M -$163 M -22.9% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 -$812 M -$117 M -16.8% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 -$736 M -$59.2 M -8.75% Dec 31, 2021 10-K 2023-03-14
Q3 2021 -$727 M -$67.8 M -10.3% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 -$713 M -$60 M -9.19% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 -$696 M -$55.9 M -8.73% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 -$677 M -$53.1 M -8.52% Dec 31, 2020 10-K 2022-03-08
Q3 2020 -$659 M -$47.8 M -7.82% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 -$653 M -$54.7 M -9.14% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 -$640 M -$55.4 M -9.48% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 -$624 M -$64.8 M -11.6% Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$611 M -$66.9 M -12.3% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 -$598 M -$68.7 M -13% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 -$584 M -$71.2 M -13.9% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 -$559 M -$58.7 M -11.7% Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$544 M -$54.3 M -11.1% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 -$529 M -$55.5 M -11.7% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 -$513 M -$56.2 M -12.3% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 -$500 M -$60.7 M -13.8% Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$490 M -$68 M -16.1% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 -$474 M -$71.8 M -17.9% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 -$457 M -$73.5 M -19.2% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 -$439 M -$76 M -20.9% Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$422 M -$71.2 M -20.3% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 -$402 M -$60.6 M -17.8% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 -$383 M -$57.3 M -17.6% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 -$363 M -$53.3 M -17.2% Dec 31, 2015 10-K 2017-03-03
Q3 2015 -$351 M -$51.4 M -17.2% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 -$341 M -$55.9 M -19.6% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 -$326 M -$53.3 M -19.6% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 -$310 M -$52.8 M -20.5% Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$299 M -$46.5 M -18.4% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 -$285 M -$37 M -14.9% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 -$273 M -$28.4 M -11.6% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 -$257 M -$16.5 M -6.86% Dec 31, 2013 10-K 2015-02-26
Q3 2013 -$253 M -$15.5 M -6.53% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 -$248 M -$15.4 M -6.59% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 -$244 M -$15.9 M -6.95% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 -$241 M -$19 M -8.58% Dec 31, 2012 10-K 2014-03-12
Q3 2012 -$237 M -$18.9 M -8.65% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 -$233 M -$19.2 M -8.99% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 -$228 M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 -$222 M -$22.5 M -11.3% Dec 31, 2011 10-K 2013-03-12
Q3 2011 -$218 M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 -$214 M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 -$199 M Dec 31, 2010 10-K 2012-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.